Buprenorphine has been shown to be effective for fentanyl users in the emergency room.

Published Date: 13 Mar 2023

A review of electronic medical records found similar associations between opioid-using patients who reported and did not report fentanyl use.

Read Full News

Latest News

The Shifting Tides of Medical Trust Through History

Why is trust in medicine waning? Historian Sophia Rosenfeld, PhD, of the University of Pennsylvania details the key reasons.

IV Dexamethasone Ranks Best Against Post-Block Rebound Pain

A new analysis ranks intravenous administration of dexamethasone as the most effective approach to prevent rebound pain after peripheral nerve block, whereas preemptive opioids offer little relief.

1 in 40 Patients With Obesity Get Clots Despite Enoxaparin

A US-based study finds that 1 in 40 patients with obesity undergoing major surgery develop venous thromboembolism within 90 days despite enoxaparin prophylaxis.

Medication Overuse Headache and Migraine: New Studies and Strategies

Neurologist Prof Diener gives an update on drug therapies and strategies for medication overuse headache, as well as fremanezumab for the prevention of migraine in children and adolescents.

New FMB Scale Predicts Driving Risk From Medications

UPV researchers created the FMB scale, a continuous index that ranks medications by driving risk more precisely than DRUID and could be integrated into e-prescribing tools.

Rib Fracture Management: Is Individualized Treatment Needed?

Aggressive pain control and selective surgical stabilization are central to rib fracture management following chest trauma.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

Why is trust in medicine waning? Historian Sophia Rosenfeld, PhD, of the University of Pennsylvania details the key reasons.

A new analysis ranks intravenous administration of dexamethasone as the most effective approach to prevent rebound pain after peripheral nerve block, whereas preemptive opioids offer little relief.

A US-based study finds that 1 in 40 patients with obesity undergoing major surgery develop venous thromboembolism within 90 days despite enoxaparin prophylaxis.

Neurologist Prof Diener gives an update on drug therapies and strategies for medication overuse headache, as well as fremanezumab for the prevention of migraine in children and adolescents.

UPV researchers created the FMB scale, a continuous index that ranks medications by driving risk more precisely than DRUID and could be integrated into e-prescribing tools.

Aggressive pain control and selective surgical stabilization are central to rib fracture management following chest trauma.

News All Time

UK Physicians & Relationships Report 2026

Work pressures are straining doctors’ relationships, with many reporting impacts on time, intimacy, and connection — particularly among younger clinicians.

ECG Challenge: Chest Tightness During Sleep

A 70-year-old man with an ICD is awoken by sudden chest tightness and is rushed to the emergency department. What does the ECG reveal?

Congo's Ebola Responders Decry Lack Of Medicine, Masks, Motorbikes

First responders fighting Democratic Republic of Congo's 17th Ebola outbreak say even basic supplies are scarce - from pain medicine, to motorbikes for contact tracing and...

Polypsychopharmacy on the Rise in Primary Care

A recent study shows that the concomitant use of two or more classes of psychotropic medication has risen among adult patients in Dutch primary care over a 10-year period.

A Post-Op Death, a Physician’s Personal Grief

Her brother’s death from a post-op pulmonary embolism left this cardiologist not only grieving but feeling guilty about the what-ifs.

10 Bucket List Vacation Ideas for Doctors

Discover the awe-inspiring destinations that top physicians' ultimate travel wish lists.

Medscape Dermatologist Compensation Report 2026

US dermatologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

High BMI, Low Activity Levels Linked to Chronic Pain

People with a high BMI or sedentary behavior have increased odds of experiencing chronic pain, although an interaction between these factors is not evident.

AAN 2026: Reflections on a New Era in Myasthenia Gravis

Dr Katherine Ruzhansky explains how new MG therapies are shifting goals from control to remission, but optimal sequencing and personalization remain key clinical challenges.

Medscape Ophthalmologist Compensation Report 2026

US ophthalmologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Psychiatrist Compensation Report 2026

US psychiatrists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Urologist Compensation Report 2026

US urologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

ME/CFS Genetics Study Wins £4.75 Million Government Backing

The UK government funding will enable whole-genome sequencing of 6000 patient samples, with researchers targeting immune and nervous system genes implicated in the disease.

Medscape Ob/Gyn Compensation Report 2026

US ob/gyns report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Pediatrician Compensation Report 2026

US pediatricians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Medscape Oncologist Compensation Report 2026

US oncologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed.

Recommended News For You

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

Women who miss their first mammogram face higher risk of breast cancer death, study finds

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Team finds broken 'brake' on cancer mutation machine.

Early palliative care billing up from 2010 to 2019 for advanced cancer

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Kate Middleton and Remission: Oncologists Weigh In

Recommended Articles For You

Predicting Incidental Prostate Cancer in BPH Surgery Patients 

What is Hemorrhagic Cystitis and How to Manage its Symptoms 

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NIH research cuts leave cancer patient facing hard choice

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Year in Review: Multiple Myeloma

4.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

5.

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

1.

Unveiling the Hidden Benefits of Lymphedema Treatment

2.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

3.

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making

4.

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership

5.

Understanding Apoplexy: Symptoms, Causes, and Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot